Literature DB >> 263513

Multimodal approach to diagnosis of hamartoma of the spleen.

J D Kuykendall, J D Shanser, T E Sumner, L R Goodman.   

Abstract

Splenic hamartoma is a benign, primary neoplasm which usually causes a mass in the left upper quadrant of the abdomen. If radionuclide studies show a space-occupying lesion in the spleen that appears solid on the ultrasonogram, and selective abdominal arteriography reveals a richly vascular splenic tumor, hamartoma of the spleen should be the preoperative diagnosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 263513     DOI: 10.1007/bf00972185

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  5 in total

1.  HAMARTOMA OF THE SPLEEN; ANGIOGRAPHIC OBSERVATIONS.

Authors:  L WEXLER; H L ABRAMS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1964-11

2.  HEMANGIOMA OF THE SPLEEN.

Authors:  B I BENJAMIN; D N MOHLER; W R SANDUSKY
Journal:  Arch Intern Med       Date:  1965-03

3.  Angiography of splenic abscesses.

Authors:  R P Jacobs; J D Shanser; D L Lawson; A J Palubinskas
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-10

4.  Hamartoma of the spleen.

Authors:  C D Teates; D L Seale; M S Allen
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1972-10

5.  The angiographic features of organizing splenic hematoma (?hamartoma).

Authors:  J C Graham; W A Weidner; M Vinik
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-10
  5 in total
  3 in total

Review 1.  Splenic hamartoma: report of a case and review of the literature.

Authors:  K Yamaguchi; S Maeda; K Kitamura
Journal:  Jpn J Surg       Date:  1989-05

2.  Splenic hamartoma: a case report and clinicopathological analysis of Japanese cases.

Authors:  Ken Okamoto; Hiromichi Maeda; Takehiro Okabayashi; Ken Dabanaka; Tsutomu Namikawa; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Clin J Gastroenterol       Date:  2011-10-28

3.  99mTc-DTPA-HSA uptake in a case of splenic hamartoma.

Authors:  H Ohta; T Komibuchi; S Kondo; M Yoshida; S Yamamoto; M Ukikusa; H Awane; N Tomono; M Shintaku
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.